|
|
| Small Stocks, Big Money™ |
| Weekly Newsletter |
|
|
|
|
|
|
|
Sharon AI Signs $1.25B AI Cloud Deal, Accelerating GPU Infrastructure Expansion
Sharon AI (Nasdaq: SHAZ) secured a transformative five-year, $1.25 billion AI infrastructure agreement with ESDS Software Solutions, reinforcing strong global demand for high-performance GPU compute. The deployment of an 8K B300 cluster in Australia positions the company to capitalize on accelerating enterprise, government, and AI-native adoption, with revenue generation from deal set to begin in Q3 2026.
|
|
|
|
OwlTing Secures $5B+ Payment Volume Pipeline as OwlPay Harbor Gains Enterprise Traction
OwlTing (Nasdaq: OWLS) onboarded 20+ enterprise clients to OwlPay Harbor in Q1 2026, representing over $5 billion in annual payment volume across their existing operations—highlighting a rapidly scaling revenue opportunity. With a global regulatory footprint and transaction-based monetization model (25–35 bps take rate), the company is entering a high-growth activation phase as cross-border payment flows transition onto its digital currency infrastructure.
|
|
|
|
|
Off The Hook Accelerates Post-IPO Growth with Expanded Capacity and AI Platform Advancements
Off The Hook (NYSE American: OTH) showcased strong post-IPO execution in Q1 2026, highlighted by a doubling of inventory financing to ~$60M, rapid broker network expansion, and $81M in luxury yacht transactions through its Autograph division. With strategic acquisitions, geographic expansion, and the launch of NextBoat AI, the company is scaling aggressively to capture share in the $57B U.S. marine market.
|
|
|
|
|
|
|
Lantern Pharma Launches Breakthrough AI Co-Scientist Platform Targeting $15B Drug Discovery Market
Lantern Pharma (Nasdaq: LTRN) will unveil its withZeta.ai platform—positioned as the first multi-agentic AI co-scientist for rare cancers—highlighting a scalable subscription model and a global market opportunity projected to exceed $15 billion by 2030. Backed by deep clinical data and regulatory expertise, the platform is designed to accelerate drug discovery timelines and unlock significant commercial potential across biopharma and research institutions.
|
|
|
|
|
Calidi Showcases Breakthrough CLD-401 Data, Advancing Toward 2026 IND Filing
Calidi Biotherapeutics (NYSE American: CLDI) will present new data on its lead asset CLD-401 at AACR 2026, highlighting its ability to drive targeted IL-15 superagonist expression within tumors and trigger strong immune responses. With IND filing expected by year-end 2026, the RedTail platform positions the company to unlock next-generation genetic medicines for high-need oncology markets.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Interview with Jay Hatfield & Sixty Degrees Pharma (NASDAQ: SXTP)
|
|
|
|
|
|
|
|---|
|
|
|
From Healthcare SaaS to Nuclear Renaissance: Latest Additions to the RedChip Nation
RedChip is pleased to welcome Comprehensive Healthcare Systems (OTCQB: CMHSF | TSXV: CHS) and Foremost Clean Energy (Nasdaq: FMST | CSE: FAT) to the RedChip Nation.
Comprehensive Healthcare Systems
(OTCQB: CMHSF | TSXV: CHS)
Comprehensive Healthcare is a high-margin SaaS provider serving the $4–6B U.S. healthcare benefits administration market. With its proprietary Novus 360 platform, CMHSF enables over 1 million members annually to access streamlined, automated healthcare and retirement benefits. Backed by 95%+ retention and over C$35M in signed contracts, the company is poised for breakout growth as it targets $100M in total contracts by 2028.
Foremost Clean Energy
(NASDAQ: FMST | CSE: FAT)
Foremost is one of the only Nasdaq-listed uranium explorers — and it's not wasting the opportunity. With strategic partnerships, including Denison Mines as its largest shareholder, Foremost controls 10 highly prospective uranium properties in Canada's world-class Athabasca Basin. Its diversified portfolio also includes lithium and gold projects, positioning the company at the forefront of the clean energy transition.
|
|
Biotech Resurgence: Platforms and Pipelines of Today's Innovators
Healthcare is entering a new era of innovation—driven by advances in biotechnology, novel therapeutics, digital health platforms, and next-generation care delivery models. From breakthrough drug pipelines to scalable healthcare infrastructure, public companies across the ecosystem are redefining how care is developed, delivered, and monetized.
|
| Unlock Smarter Investing with RedChat |
 |
| Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market. |
| Access RedChat now, free of charge. |
|
|
|
|
Recent Research Coverage Updates
| Company |
Rating |
Price Target |
Firm |
Report Date |
| The Metals Company (Nasdaq: TMC) | Buy | $11 | Wedbush | February 22, 2026 |
| The Metals Company (Nasdaq: TMC) | Buy | $9 | Cantor Fitzgerald | February 22, 2026 |
| Alliance Entertainment (Nasdaq: AENT) | Buy | $9 | Noble Capital | February 13, 2026 |
| Alliance Entertainment (Nasdaq: AENT) | Buy | $8 | Maxim | February 13, 2026 |
| XTI Aerospace (Nasdaq: XTIA) | Buy | $3 | Maxim | February 6, 2026 |
| Sixty Degrees Pharmaceuticals (Nasdaq: SXTP) | Buy | $24 | HC Wainwright | February 2, 2026 |
| Off The Hook (NYSE American: OTH) | Buy | $10 | ThinkEquity | January 19, 2026 |
| Enlivex Therapeutics (Nasdaq: ENLV) | Buy | $13 | HC Wainwright | January 13, 2026 |
| NioCorp Developments (Nasdaq: NB) | Buy | $8.7 | Freedom Capital Markets | January 7, 2026 |
|
|
|
|
 |
| Small Stocks, Big Money™ Podcast |
| The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else. |
| Available on: |
|
|
|
|
|
|
Upcoming Events
|
|
|
Alliance Entertainment Holding Corporation (NASDAQ: AENT)
4:15pm Eastern
Alliance Entertainment is a leading distributor and fulfillment partner at the center of the entertainment and collectibles ecosystem.
|
|
|
|
Nexalin Technology (NASDAQ: NXL)
4:15pm Eastern
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
|
|
|
|
Archived Events
|
|
|
AI Investor Conference: From Data Centers to Breakthrough Use Cases
9:30am Eastern
Artificial intelligence is rapidly transforming how data is processed, decisions are made, and products are delivered across the global economy.
|
|
|
|
Quote of the Week
|
“ If you want to invest in the microcap space buy companies not stocks, if you buy stocks, the daily fluctuations and lack of liquidity will drive you crazy. ” |
|
|
— Byron Roth, ROTH Capital |
|
|
|
|
Order “Small Stocks, Big Money™” Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
Using dollar-cost averaging to build positions.
|
|
|
|
|
|
Copyright © 2026 Redchip Companies, Inc. |
|
|
{{ site_settings.company_name }} {{ site_settings.company_street_address_1 }} {{ site_settings.company_street_address_2 }} {{ site_settings.company_city }} {{ site_settings.company_state }} {{ site_settings.company_zip }} {{ site_settings.company_country }}
|
|
|
|
|
You are receiving this email because you have subscribed to receive updates from us. Should you wish to cancel your subscription, please click here to manage preferences. |
|
|
|
|
